Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
Pozycja w akcjach #509
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Cena akcji
$7.88
Kapitalizacja rynkowa
$50.25B
Zmiana (1 dzień)
-1.11%
Zmiana (1 rok)
-7.06%
Kraj
CN
Handel Jiangsu Hengrui Medicine Co., Ltd. (600276)

Kategoria

Historia ceny akcji dla Jiangsu Hengrui Medicine Co., Ltd. (600276)
Najwyższa cena zamknięcia: $7.90 dnia 2026-08-01

Najniższa cena zamknięcia: $0.04 dnia 2005-07-01
Historia cen akcji firmy Jiangsu Hengrui Medicine Co., Ltd. od 2005 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -3.56%
2025 33.70%
2024 2.96%
2023 15.17%
2022 -30.24%
2021 -37.82%
2020 50.21%
2019 73.88%
2018 25.89%
2017 85.51%
2016 3.95%
2015 100.95%
2014 12.39%
2013 42.52%
2012 4.92%
2011 -16.03%
2010 40.18%
2009 61.62%
2008 -8.70%
2007 153.91%
2006 239.46%
2005 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$171.67 -
DE
$166.06 27.73%
DE
$36.29 22.66%
JP
$228.90 41.12%
CH
$21.45 14.41%
IN